期刊文献+

不同超促排卵方案对高龄患者体外受精结局影响的研究 被引量:5

The observation of effect of two different COH protocols on the IVF-ET outcome of aged patients.
下载PDF
导出
摘要 目的:探讨两种不同超促排卵方案对接受体外受精胚胎移植(IVF-ET)手术的高龄不孕患者卵泡液中IL-15、IL-18、IL-12/IL-23亚基p40水平及妊娠结局的影响,以及高龄患者最佳的超促排卵方案。方法:选择2008年4月~2008年12月在我院行IVF-ET手术的40例年龄35~43岁的不孕妇女为研究对象,随机分为两组,A组用促性腺激素激动剂+促性腺激素(GnRH-a+Gn)短方案,B组用促性腺激素拮抗剂+促性腺激素(GnRH-ant+Gn)的超促排卵(COH)方案,测定两组患者HCG注射日、取卵日、胚胎移植日外周血甾体激素水平及取卵日卵泡液IL-15和IL-12/IL-23亚单位p40的浓度,比较两组患者的周期结局。结果:B组患者的HCG注射日血清E2值和卵泡液IL-15含量低于A组,移植日P水平高于A组,差异有统计学意义(P<0.05);A组Gn用药天数、剂量、移植日E2水平高于B组,但差异无统计学意义(P>0.05);两组卵泡液E2和P水平、获卵数、受精率、优质胚胎率、流产率和卵泡液细胞因子IL-18、IL-12/IL-23亚基p40含量无统计学差异(P>0.05)。B组临床妊娠率高于A组(45%vs 35%),但差异无统计学意义(P>0.05)。结论:接受IVF-ET手术的高龄不孕患者,临床选择促性腺激素拮抗剂+促性腺激素的超促排卵方案可获得较好的妊娠结局。 Objective:To explore the influence of two different COH protocols on ova-rian follicular concentration of IL-12,IL-15,IL-18 and p40 subunit of IL-12 and 23 and IVF-ET outcome,and the better COH protocols for aged infertility.Methods:Forty infertility patients who were 35~45 years old and received in-vitro-fertilization and embryo transfer(IVF-ET) from Apr.2008 to Dec.2008 were randomly divided into two groups,the patients in group A accepted the GnRH-a+Gn protocol,while the patients in group B accepted the GnRH-ant+Gn protocol.The concentration of blood serum hormone levels on hCG injecting day,eggs day,embryo transfer day,and ovarian follicular concentration of IL-12,IL-15,IL-18 and p40 subunit of IL-12 and 23 were determined,the days and dose of Gn,the amount of eggs,the number of the high quality embryo were measured,the clinic pregnancy rate and miscarriage rate between A,B groups were compared.Results:The level of serum estrogen(E2) on the HCG injecting day and ovarian follicular concentration of IL-15 of group B patients were less than that of group A,P levels on the embryo transfer day was higher than that of group A(P0.05).The number of days,dosage of Gn and the level of E2 on the embryo transfer day of group A were higher than that in group B,but there was no statistical significance(P0.05).There were no significant difference in the level of E2,P in the ovarian follicular,the number of eggs,the fertility rate,the high-quality embryos rate,abortion rates and follicular fluid cytokine IL-18,IL-12/IL-23 subunit p40 concentration between the two groups(P0.05).The clinical pregnancy rate of group B was higher than that of group A(45% vs 35%),but there was no statistical significance(P0.05).Conclusion:For aged infertility,the GnRH-ant protocol is excelled which can have better IVF-ET outcome.
出处 《现代妇产科进展》 CSCD 北大核心 2010年第5期366-369,共4页 Progress in Obstetrics and Gynecology
关键词 卵泡液 细胞因子 促性腺激素拮抗剂 促性腺激素激动剂 高龄不育 女性 Follicular fluid Cytokine GnRH-ant GnRH-a Aged infertility female
  • 相关文献

参考文献12

  • 1张亚红,徐仙.卵泡液细胞因子与体外受精-胚胎移植的关系[J].中国妇幼健康研究,2008,19(1):62-64. 被引量:7
  • 2Felverbaum R, Diedrich K. Ovarian stimulation in ART: use of GnRH-ant agonists. Fertil Reprod Med. Proceedings of the ⅩⅥ World Congress on Fertility and Sterility[ R]. San Francisco, 1998 : 113-124.
  • 3李豫峰,镇春,何巧花,胡娟,章汉旺,刘玉芹,刘群,魏玉兰,朱桂金,田洪帅.体外受精-胚胎移植患者妊娠率与年龄及多精受精关系的研究[J].中国优生与遗传杂志,2008,16(1):102-103. 被引量:16
  • 4Vujisic S, Lepej SZ, Emedi I, et al. Ovarian follicular concentration of IL-12 ,IL-15 ,IL-18 and p40 subunit of IL-12 and IL-23 [ J ]. Hum Reprod ,2006,21:2650-2655.
  • 5Wozniak TM, Ryan AA, Britton WJ. Interleukin-23 restores immunity to Mycobaeterium tuberculosis infection in IL-12p40-defieient mice and is not required for the development of IL-17-secreting T cell responses [ J ]. J Immunol,2006,177 : 8684-8692.
  • 6Wilson R, Jenkins C, Miller H, et al. Abnormal cytokine levels in non-pregnant women with a history of recurrent miscarriage[ J ]. Eur J Obstet Gynecol Reprod Biol,2004, 115:51-54.
  • 7Wilson R, Moor J, Jenkins C, et al. Abnormal first trimestrer serum interleukin 18 levels are associated with a poor outcome in women with a history of recurrent miscarriage [ J]. Am J Reprod Immunol,2004,51:156-159.
  • 8Ledee-Bataille N, Olivennes F, Kadoch J, et al. Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer [ J ]. Hum Reprod,2004,19 : 1968-1973.
  • 9Krueger GG, Langley RG, Leonardi C, et al. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis[ J]. N Engl J Med ,2007,356:580-592.
  • 10Gazvani MR, Bates M, Vince G, et al. Follicular fluid concentrations of interleukin-12 and interleukin-8 in IVF cycles[ J]. Fertil Steril,2000,74:953-958.

二级参考文献24

  • 1张镜如.生理学(第4版)[M].北京:人民卫生出版社,1996.401-403.
  • 2裘法祖.外科学(第4版)[M].北京:人民卫生出版社,1997.551.
  • 3庄广伦.现代辅助生殖技术[M].北京:人民卫生出版社,2005:408.
  • 4Chuang CC, et al. Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization [J]. Fertil Steril, 2003, 79 (1) : 63-68.
  • 5Battaglia D, Miller M. The aging oocyte [J]. Endocrinologist, 1997, 7:1 -5.
  • 6Bar Hava I,et al. Natural cycle in vitro fertilization in women aged over 44 years [J]. Gynecol Endocrino1,2000,14:248 - 252.
  • 7Feng H, Hershlag. Fertilization abnormalities following human in vitro fertilization and intracytoplasmic sperm injection [J]. Microse Res Tech,2003,61:358 -61.
  • 8Aneuploid analysis of tripronuclear zygotes derived from in vitro fertilization and intracytoplasmic sperm injection in humans [J]. Fertility and sterility,2005,83 ( 6 ).
  • 9Aasland D,Schuster B,Kallen K J.Analysis of the leukemia inhibitory factor receptor functional domains by chimeric receptors and cytokines[J].Biochemistry,2003,42(18):5244-5252.
  • 10Strandell A,Thorburn J,Wallin A.The presence of cytokines and growth factors in hydrosalpingeal fluid[J].Assist Reprod Genet,2004,21(7):241-247.

共引文献30

同被引文献70

  • 1皮洁,何驰华,朱敬香,卢亚祖,李军,马朝琼.促性腺激素释放激素激动剂长短方案在体外受精胚胎移植中的比较[J].长江大学学报(自科版)(下旬),2006,3(4):278-280. 被引量:2
  • 2阳翎,高士友,邓朝晖,唐慧珍,陈辉莲,李燕,汤倩倩.多剂量促性腺激素释放激素拮抗剂在体外受精—胚胎移植促超排卵中的应用效果[J].医学临床研究,2007,24(4):535-537. 被引量:6
  • 3Ragni G, Vegetti W, Riccaboni A, et al. Comparis on of GnRH agonists and ant aganists in assist ed reproducti on cycles of pa- tients at high risk of ovarian hyperstimulations yndrome [ J ]. Hum Reprod, 2005,20 (9) :2421-2425.
  • 4Bart CJ, Fauser MD, Paul D. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist co-treatment duringovar- ian hyperstimulation for in vitro fertilization so slow [ J ]. Fertil Steril, 2005,83 (6) : 1607-1611.
  • 5Bodri D, Sunkara SK, Coomarasamy A. Gonadotropinreleasing hormone agonists versus antagonists for controlled ovarian hypers- timulation in oocyte donors: asystematic reviewand recta-analysis [J]. Fertil Steril, 2011,95(1 ):164-169.
  • 6Check ME, Check JH, Choel JK, et al. Effect of antagonists vs ag- onists on in vitro fertilization outcome [ J ]. Clin Exp Obstet Gyne- col, 2004,31 (4) :257-259.
  • 7Tarlatzis BC, Fauser BC, Kolibianakis EM, et al. GnRH antago- nists in ovarian stimulation for IVF [ J ]. Hum Reprod Update, 2006,12(4) :333-340.
  • 8Shapiro DB. GnRH ant agonists normal responder patients [ J ]. Fertil Steril, 2003,80( Suppl 1 ) :8-15.
  • 9Griesinger G, Felberbaum R, Dicdrich K. GnPttt antagoni stsino- varian stimulation: atreatment regimen of clinicians second choice Data from the Germ annational IVF registry [ J ]. Hum Reprod, 2005,20(9) :2373-2375.
  • 10甄秀梅,乔杰,李蓉.GnRH拈抗剂在卵巢反应不良患者中的应用[J].中同优生与遗传杂志,2009,17(4):118-120.

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部